Results 201 to 210 of about 2,452,838 (337)
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Risk factors for non-communicable diseases among Bangladeshi adults: an application of generalised linear mixed model on multilevel demographic and health survey data. [PDF]
Nahin KSA, Jannatul T.
europepmc +1 more source
The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses? [PDF]
Ben ÂJ +9 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Mei Tian,1 Qiulian Xing,2 Xiao Wang,2 Xiqing Yuan,2 Xinyu Cheng,2 Yu Ming,2 Kexin Yin,2 Zhi Li,2 Peng Wang2 1Library, Shandong Normal University, Jinan, People’s Republic of China; 2School of Psychology, Shandong Normal University, Jinan, People’s ...
Tian M +8 more
doaj
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials. [PDF]
Touraine C +5 more
europepmc +1 more source
On modeling the single period spare parts distribution system design problem by mixed integer linear optimization [PDF]
Hazal Ercan
openalex
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source

